Literature DB >> 11756508

The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function.

Ninel Gregori1, Christoph Pröschel, Mark Noble, Margot Mayer-Pröschel.   

Abstract

We have found that the tripotential glial-restricted precursor (GRP) cell of the embryonic rat spinal cord can give rise in vitro to bipotential cells that express defining characteristics of oligodendrocyte-type-2 astrocyte progenitor cells (O2A/OPCs). Generation of O2A/OPCs is regulated by environmental signals and is promoted by platelet-derived growth factor (PDGF), thyroid hormone (TH) and astrocyte-conditioned medium. In contrast to multiple observations indicating that oligodendrocyte precursor cells in the embryonic day 14 (E14) spinal cord are ventrally restricted, GRP cells are already present in both the dorsal and ventral spinal cord at E13.5. Ventral-derived GRP cells, however, were more likely to generate O2A/OPCs and/or oligodendrocytes than were their dorsal counterparts when exposed to TH, PDGF, or even bone morphogenetic protein-4. The simplest explanation of our results is that oligodendrocyte generation occurs as a result of generation of GRP cells from totipotent neuroepithelial stem cells, of O2A/OPCs from GRP cells and, finally, of oligodendrocytes from O2A/OPCs. In this respect, the responsiveness of GRP cells to modulators of this process may represent a central control point in the initiation of this critical developmental sequence. Our findings provide an integration between the earliest known glial precursors and the well-studied O2A/OPCs while opening up new questions concerning the intricate spatial and temporal regulation of precursor cell differentiation in the CNS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756508      PMCID: PMC6757619     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes.

Authors:  A Espinosa de los Monteros; M Zhang; J De Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

2.  Developmental expression in central and peripheral nervous system of oligodendrocyte cell surface antigens (O antigens) recognized by monoclonal antibodies.

Authors:  M Schachner; S K Kim; R Zehnle
Journal:  Dev Biol       Date:  1981-04-30       Impact factor: 3.582

3.  Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells.

Authors:  O Bögler; D Wren; S C Barnett; H Land; M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  Isolation, cloning and characterization of a putative type-1 astrocyte cell line.

Authors:  K J Seidman; A L Teng; R Rosenkopf; P Spilotro; J A Weyhenmeyer
Journal:  Brain Res       Date:  1997-04-04       Impact factor: 3.252

5.  Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development.

Authors:  R Bansal; A E Warrington; A L Gard; B Ranscht; S E Pfeiffer
Journal:  J Neurosci Res       Date:  1989-12       Impact factor: 4.164

6.  Oligodendroblasts distinguished from O-2A glial progenitors by surface phenotype (O4+GalC-) and response to cytokines using signal transducer LIFR beta.

Authors:  A L Gard; W C Williams; M R Burrell
Journal:  Dev Biol       Date:  1995-02       Impact factor: 3.582

7.  Differentiation-regulated loss of the polysialylated embryonic form and expression of the different polypeptides of the neural cell adhesion molecule by cultured oligodendrocytes and myelin.

Authors:  J Trotter; D Bitter-Suermann; M Schachner
Journal:  J Neurosci Res       Date:  1989-04       Impact factor: 4.164

8.  Bone morphogenetic proteins inhibit proliferation, induce reversible differentiation and prevent cell death in astrocyte lineage cells.

Authors:  J S D'Alessandro; E A Wang
Journal:  Growth Factors       Date:  1994       Impact factor: 2.511

9.  Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGF alpha-receptors.

Authors:  A Hall; N A Giese; W D Richardson
Journal:  Development       Date:  1996-12       Impact factor: 6.868

10.  Bmp activity establishes a gradient of positional information throughout the entire neural plate.

Authors:  K A Barth; Y Kishimoto; K B Rohr; C Seydler; S Schulte-Merker; S W Wilson
Journal:  Development       Date:  1999-11       Impact factor: 6.868

View more
  36 in total

Review 1.  From stem cells to oligodendrocytes: prospects for brain therapy.

Authors:  Cui P Chen; Mary E Kiel; Dorota Sadowski; Randall D McKinnon
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

2.  Glial restricted precursor cell transplant with cyclic adenosine monophosphate improved some autonomic functions but resulted in a reduced graft size after spinal cord contusion injury in rats.

Authors:  Yvette S Nout; Esther Culp; Markus H Schmidt; C Amy Tovar; Christoph Pröschel; Margot Mayer-Pröschel; Mark D Noble; Michael S Beattie; Jacqueline C Bresnahan
Journal:  Exp Neurol       Date:  2010-10-30       Impact factor: 5.330

Review 3.  Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury.

Authors:  Charles Nicaise; Dinko Mitrecic; Aditi Falnikar; Angelo C Lepore
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

4.  Phenotypic analysis of astrocytes derived from glial restricted precursors and their impact on axon regeneration.

Authors:  Christopher Haas; Birgit Neuhuber; Takaya Yamagami; Mahendra Rao; Itzhak Fischer
Journal:  Exp Neurol       Date:  2011-11-10       Impact factor: 5.330

5.  Astroglial-derived periostin promotes axonal regeneration after spinal cord injury.

Authors:  Chung-Hsuan Shih; Michelle Lacagnina; Kelly Leuer-Bisciotti; Christoph Pröschel
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

6.  Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI.

Authors:  Ke Li; Elham Javed; Tamara J Hala; Daniel Sannie; Kathleen A Regan; Nicholas J Maragakis; Megan C Wright; David J Poulsen; Angelo C Lepore
Journal:  Mol Ther       Date:  2014-12-10       Impact factor: 11.454

Review 7.  Stem cells and the origin and propagation of brain tumors.

Authors:  Brian A Emmenegger; Robert J Wechsler-Reya
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

8.  Human fetal radial glia cells generate oligodendrocytes in vitro.

Authors:  Zhicheng Mo; Nada Zecevic
Journal:  Glia       Date:  2009-04-01       Impact factor: 7.452

9.  Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures.

Authors:  Manjeet K Paintlia; Ajaib S Paintlia; Mushfiquddin Khan; Inderjit Singh; Avtar K Singh
Journal:  J Neurochem       Date:  2008-01-12       Impact factor: 5.372

Review 10.  Expression of thyroid hormone receptor isoforms in the oligodendrocyte lineage.

Authors:  Louis L Sarliève; Angeles Rodríguez-Peña; Keith Langley
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.